US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

37.18

+0.42321.15%

Volume:1K

Turnover:48.43K

Market Cap:17.47M

PE:- -

High:37.49

Open:37.49

Low:37.11

Close:36.75

52wk High:37.90

52wk Low:28.87

Shares:469.95K

Float Shares:469.95K

Volume Ratio:0.59

T/O Rate:0.28%

Dividend:0.41

Dividend Rate:1.10%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Austar Lifesciences H1 Profit Drops on Higher R&D Spending

WuXi Biologics H1 Net Profit up on Margin Expansion

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100

Redefining Roles: Commercial Health Insurance Enters a New Era of Partnership in China's Next Five-Year Plan

ETF Market Daily: Healthcare Sector Shows Solid Valuations While Innovative Drug Subsegments See Dense Catalysts, Spotlight on Hang Seng Biotech ETF and STAR Innovative Drug ETF

Sagimet Biosciences advances AURORA clinical trial

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Market Sees Gains Across More Than 4,200 Stocks as Innovative Drug Sector Surges and Gold Shares Slip | Huabao Fund 3A Daily Report (August 25, 2026)

ETF Market Wrap (Aug 25): Interim Results Validate Innovative Drug Sector Rally While Gold's Pullback Caps Mining Stock Gains

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

Molecular Partners H1 Net Loss Narrows on Lower R&D Expenses

Coordinated Growth Fuels Regional Industrial Advancement

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

Alkermes’ Alixorexton Posts Positive Phase 2 Vibrance-1 Results in Narcolepsy Type 1 Study

The Lancet Neurology Publishes Data from Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults with Narcolepsy Type 1

THOMSON REUTERS

FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/MEDX/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":37.1775,"timestamp":1788379200000,"preClose":36.7543,"halted":0,"volume":1299,"delay":0,"changeRate":0.011514299007191031,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Pre-Mkt","change":0.4232,"latestTime":"09-03 05:18:42 EDT","open":37.4899,"high":37.4899,"low":37.105,"amount":48432,"amplitude":0.010472,"askPrice":44.13,"askSize":100,"bidPrice":14.95,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788442200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":37.1775,"sharesOutstanding":569946,"nav":36.75,"aum":17270515.5,"dividendRate":0.010972,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":37.105,"preClose":37.1775,"latestTime":"16:10 EDT","volume":6,"amount":222.85,"timestamp":1788379804403,"change":-0.0725,"changeRate":-0.00195,"amplitude":0},"volumeRatio":0.5852933462541232},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5852933462541232,"shares":469946,"dividePrice":0.4079,"high":37.4899,"amplitude":0.010472,"preClose":36.7543,"low":37.105,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":37.1775,"eps":0,"divideRate":0.010972,"volume":1299,"delay":0,"ttmEps":0,"open":37.4899,"prevYearClose":33.2024,"prevWeekClose":36.5564,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":37.2921,"twentyDayClose":35.2867,"sixtyDayClose":34.181},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662732450","title":"China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732450","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732450?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:48","pubTimestamp":1787662122,"startTime":"0","endTime":"0","summary":"China's Innovent Biologics H1 revenue, profit rise on strong product salesOverviewChina biopharma firm's H1 revenue rose 44.8% yr/yr on strong product sales growthNet profit for H1 grew 50.2% yr/yr, s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","KURE","IE00B42XCP33.USD","SG9999015986.USD","LU0965509283.SGD","JDOC","ABBV","IE00BVYPNW00.USD","LU1496350171.SGD","IXJ","BK0239","PJP","IE00BGHQF631.EUR","IE00BLSP4452.SGD","IE0002141913.USD","LU1037948541.HKD","IE00B3PB1722.GBP","01167","LU0942090050.USD","01911","LU2148510915.USD","LU2097828631.EUR","LU0456855351.SGD","XLV","LU0234572021.USD","LU0455707207.USD","LU0203345920.USD","LU0098860793.USD","PPH","AGNG","MEDX","LU0203347892.USD","RXL","LU0170899867.USD","VHT","688331","LU2089283258.USD","LU2237443895.HKD","LU2097828805.USD","LU1732800096.USD","FTXH","LU1989772840.SGD","IE000MB6IJN5.SGD","LU0029864427.USD","GLAM","FHLC","TRUH","01801","688428","LU1551013342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662073296","title":"Austar Lifesciences H1 Profit Drops on Higher R&D Spending","url":"https://stock-news.laohu8.com/highlight/detail?id=2662073296","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662073296?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:44","pubTimestamp":1787661880,"startTime":"0","endTime":"0","summary":"Austar Lifesciences H1 profit drops on higher R&D spendingOverviewChina life sciences solutions firm's H1 revenue rose 12% yr/yrProfit attributable to owners fell sharply, with EPS down to RMB 0.02 fr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU0689626769.HKD","IE0002270589.USD","LU0965508806.USD","LU1718418525.SGD","LU0545039389.USD","JDOC","IE000WAW04H5.SGD","LU1496350171.SGD","LU0234572021.USD","MEDX","LU1267930573.SGD","TRUH","IE00B19Z3B42.SGD","LU0661504455.SGD","SG9999015952.SGD","FHLC","FTXH","688331","LU2433249047.HKD","IE00B19Z3581.USD","IXJ","AGNG","VHT","ABBV","IYH","LU0289739699.SGD","IE000BZT7R73.USD","LU1732800096.USD","IE000SO60NU8.SGD","06118","LU1732799900.SGD","LU1989772840.SGD","LU0820561818.USD","PPH","LU0203347892.USD","LU1093756168.USD","IE00BBT3K403.USD","LU0211327993.USD","LU2347655073.USD","LU2347655156.SGD","LU0689472784.USD","LU1057294990.SGD","RXL","LU0256863811.USD","PJP","LU0417517546.SGD","GLAM","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732647","title":"WuXi Biologics H1 Net Profit up on Margin Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732647","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732647?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:41","pubTimestamp":1787661670,"startTime":"0","endTime":"0","summary":"WuXi Biologics H1 net profit up on margin expansionOverviewChina biologics CDMO's H1 revenue grew 18% yr/yr, net profit attributable up 4%Gross profit margin expanded to 46.2% from 42.7%Growth driven ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","XLV","PPH","KURE","LU0289961442.SGD","MEDX","BK1141","LU2133065610.SGD","VHT","LU0949170772.SGD","LU0965509010.AUD","PJP","IXJ","LU2087621335.USD","LU2237443978.SGD","02269","TRUH","LU0211327993.USD","SG9999015952.SGD","LU1839511570.USD","SG9999001440.SGD","688331","RXL","IE0002270589.USD","LU0198837287.USD","LU1934455863.HKD","LU0234572021.USD","LU1983299246.USD","LU1496350502.SGD","LU1670627923.USD","FTXH","JDOC","LU0708994859.HKD","LU2112291526.USD","IE000F7OJYX1.SGD","ABBV","FHLC","GLAM","LU0234570918.USD","LU0052750758.USD","LU1496350171.SGD","SG9999015945.SGD","AGNG","IE00BN8TJ469.HKD","SG9999003800.SGD","IYH","LU1057294990.SGD","LU1989772923.USD","BK4533","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662673234","title":"Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662673234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662673234?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:37","pubTimestamp":1787661420,"startTime":"0","endTime":"0","summary":"Underappreciated value stocks provide 'ballast' for investors, says Bank of AmericaEstée Lauder earns a rank among high-growth stocks beyond AI.In 2021 strategists at Bank of America's BofA Securities","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","LU2237438978.USD","SG9999015986.USD","LU0289739343.SGD","MHIP","LU1839511570.USD","SG9999014906.USD","LU0310799852.SGD","TRUR","LU2065170008.USD","LU0738911758.USD","LU0234570918.USD","LLYX","LU2552382132.HKD","LU1069344957.HKD","LU1201861165.SGD","JPRE","LU1291159041.SGD","IE00BGHQF748.EUR","LU1244550577.SGD","IE0004445015.USD","LU0859254822.USD","ROBN","LU0868494617.USD","GPZ","SGXZ81514606.USD","BK4503","LU0553294199.USD","LU1548497426.USD","BAC","LU1551013425.SGD","LU2462157665.USD","LU2237443622.USD","LU1880398471.USD","VHT","RITA","IE00BKDWB100.SGD","LU2112291526.USD","LU0708995401.HKD","AGNG","LU1983299246.USD","LU0203345920.USD","LU1366192091.USD","IE00B1XK9C88.USD","LU2106854487.HKD","BYRE","LU2237443895.HKD","LU0353189763.USD","PRVT","HOOD","LU0672654240.SGD","LU2133065610.SGD","LU0965509010.AUD","LU1496350502.SGD","REIX","LU1236620750.USD","IE00B2B36J28.USD","LU0661504455.SGD","LU1244550494.USD","IE00BBT3K403.USD","LU1718418525.SGD","SG9999014898.SGD","LU2237957811.SGD","IE00BN8TJ469.HKD","IE0004445239.USD","LU1064131342.USD","LU2362540622.SGD","WELL","LU0058720904.USD","SPRE","IE000MB6IJN5.SGD","BK4183","LU0395794307.EUR","BK4139","LU0689626769.HKD","LU1057294990.SGD","LU0942090050.USD","LU0882574139.USD","XLF","SG9999018857.SGD","TMED","LU1868837300.USD","SGXZ99366536.SGD","LU2404859667.USD","LU0889565916.HKD","TBXU","BK4539","HOOI","LU0210536198.USD","LU0640476718.USD","IE000WAW04H5.SGD","LU0114720955.EUR","LU2746668461.USD","SG9999011175.SGD","LU0029864427.USD","IE00BSNM7G36.USD","LU0198837287.USD","IAI","LU0098860793.USD","HOOG","LU1935042991.SGD","BK4225","IE00B3PB1722.GBP","SG9999014880.SGD","LLII","SG9999014005.SGD","WDNA","GB00BDT5M118.USD","HOOW","MEDX","EL","IE0005OL40V9.USD","HOOX","BK4558","LU1934455863.HKD","LU1861559042.SGD","LU1989772923.USD","LU2028103732.USD","CNC","LU2756315318.SGD","EKG","IE000F7OJYX1.SGD","LU1668664300.SGD","LU1989771016.USD","SG9999015952.SGD","LU0823434740.USD","LU0354030438.USD","LU0949170772.SGD","LU2237443978.SGD","LBO","IE00B64PRP62.GBP","LU1232071149.USD","LU1074936037.SGD","LU0345770993.USD","LU1267930490.SGD","LU0057025933.USD","LU0320765646.SGD","LU2065171402.SGD","LU1506573853.SGD","BK4547","RXL","LU2087625088.SGD","LU2471134952.CNY","SG9999014013.SGD","LU2089284900.SGD","LU1623119135.USD","SG9999014914.USD","LU0965509101.SGD","LU0130103400.USD","IE00BZ1G4Q59.USD","SGXZ31699556.SGD","LU0912757837.SGD","LU1929549753.HKD","PSR","C","LU0306806265.USD","IE00BKPKM429.USD","LU0109391861.USD","DXCM","BBH","IHF","LU0211331839.USD","LU0432979614.USD","LU0348723411.USD","LU1989772840.SGD","LU0133085943.USD","LU2433249047.HKD","IE00B4JS1V06.HKD","BK4227","LU2417539215.USD","LU0314104364.USD","REZ","BK4581","LU1804176565.USD","ELIL","LU1935042488.USD","LU2168564222.USD","VGSR","LU0128525929.USD","LU1144417596.USD","LU1119994496.HKD","LU2168563687.JPY","LU2362541513.USD","LU0472753341.HKD","DFAR","LU0820561909.HKD","LU0477156953.USD","FXH","LU2491050071.SGD","LU2357627491.SGD","LU0006306889.USD","LU2087621335.USD","LU0345770308.USD","LU0256863811.USD","IE0002270589.USD","HOOC","LU2360106947.USD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU0820561818.USD","CNCG","LU2125909593.SGD","LU0323591593.USD","CLIM","DPRE","GQRE","LU0238689110.USD","FTXH","LU1551013342.USD","LU1699723380.USD","IE00BDGV0183.EUR","LU0354030511.USD","LU0787776722.HKD","LU0882574055.USD","LU0795875086.SGD","PPH","LU0726765562.USD","IE000SO60NU8.SGD","IE00BMPRXN33.USD","LU1261432733.SGD","IE00B19Z3581.USD","LU2168564149.EUR","IE00BVYPNW00.USD","FRI","LLYZ","LU1267930730.SGD","FTXO","LU1035775433.USD","LU1868836591.USD","LU1894683264.USD","BK4566","LU0162691827.USD","SGXZ57979304.SGD","OZEM","IE00BJJMRY28.SGD","LU0320765992.SGD","LU0208291251.USD","IE00BKVL7J92.USD","LU2063271972.USD","LU0963586101.USD","BK4550","LU1935043536.SGD","LU1935043023.USD","LU1363072403.SGD","LU0061475181.USD","LU0471298694.HKD","LU1069347547.HKD","REGN","ABBV","LU0417517546.SGD","LU0079474960.USD","LU2125154778.USD","IE00B1BXHZ80.USD","IBB","LU0511384066.AUD","XLV","LU1201861249.SGD","LU0158827781.USD","LU2491049909.HKD","IQRA","BK4135","LU1585245621.USD","LU2210150020.SGD","LU1720051017.SGD","LU0823434583.USD","IBKR","LU0528227936.USD","LU0985320562.USD","LU0070302665.USD","LU2125909247.SGD","LU1670627923.USD","CFG","LGLV","LU0106261372.USD","LU2347655156.SGD","LU0314106906.USD","IE0000B7K699.USD","LU2023250330.USD","PODD","THNR","LU2095319765.USD","JDOC","LU2023251221.USD","LU2404859741.USD","LU0130518102.USD","LU1145028129.USD","LU0225283273.USD","BK4211","LU1732800096.USD","LU2023250504.SGD","LU0096364046.USD","LU2211817866.USD","BK4106","LU0149725797.USD","LU0466842654.USD","LU2237957902.USD","AVRE","CURE","IE00B775H168.HKD","LU0289960550.SGD","HOOZ","FNCL","SG9999014021.USD","LU2125154935.USD","BK4559","LU0266013472.USD","LU2089283258.USD","TFNS","XLRE","LU0708994859.HKD","LU0456855351.SGD","LU1861558580.USD","BPAY","IYF","PSP","LU1267930227.SGD","LU2210149790.SGD","PJP","RSPR","FINX","IYG","LU0689472784.USD","LU0690374961.EUR","BK4598","IE00BMPRXR70.SGD","LU2468319806.SGD","LU0786609619.USD","LU1691799644.USD","LU2552382058.USD","LU0211327993.USD","LU1935042215.USD","HOOY","LU1732799900.SGD","LU0109394709.USD","LU2756315664.SGD","LU1003077747.HKD","LU0971096721.USD","HRTS","REET","LU0965509283.SGD","LU0310800379.SGD","BK4154","SG9999003800.SGD","IE00BJT1NW94.SGD","LU1791807156.HKD","IE00BJJMRX11.SGD","URE","BK4554","LU0795875169.SGD","BK4553","LU0106831901.USD","LU0823416689.USD","LU0072461881.USD","BBRE","SG9999017495.SGD","LU0861579265.USD","SG9999015978.USD","HAUS","IE00B7KXQ091.USD","IAT","RNTY","LU1868837136.USD","IE00BHPRN162.USD","IE00BVYPNV92.GBP","LU1037948541.HKD","LU2456880835.USD","LU2491050154.USD","IE00B42XCP33.USD","LU2896262040.SGD","UYG","IE00BK4W5L77.USD","LU0289739699.SGD","IE00BGHQF631.EUR","LU2264538146.SGD","BK4551","LU2236285917.USD","HUM","LU0690374615.EUR","CANC","LLY","LU2237443382.USD","LU0390134368.USD","IE00B4R5TH58.HKD","CRPT","LU1323610961.USD","LU0175139822.USD","LU0316494557.USD","LU1720051108.HKD","BK4599","LU1880398554.USD","LU2211815571.USD","LU0234572021.USD","IE00BFSS8Q28.SGD","LU2237443465.HKD","ARES","BK4533","LU2129689431.USD","LU1814569148.SGD","LU0211328371.USD","LU1712237335.SGD","LU0980610538.SGD","LU1868836757.USD","LU1974910355.USD","SGXZ51526630.SGD","BK4127","LU0256863902.USD","LU1670628061.USD","BK4588","LU1037948897.HKD","BK4082","LU1061106388.HKD","IE0034235188.USD","LU0128525689.USD","LU0353189680.USD","SCHH","TRUH","ILDR","LU1035773651.USD","HOYY","IE00BWXC8680.SGD","IE0001KFT4U8.USD","LU0320765489.SGD","LU0289961442.SGD","VNQ","IHE","IE00BFSS7M15.SGD","LU0648000940.SGD","RWO","LU1496350171.SGD","LU0648001328.SGD","LU0320765059.SGD","LU2471134796.USD","ELIS","LU1894683348.USD","LU0174119429.USD","SG9999015945.SGD","IE00BK4W5M84.HKD","LU2129689605.HKD","IXJ","LU0321505868.SGD","LU0203202063.USD","LU1934455277.USD","LU2347655073.USD","LU0310800965.SGD","LU2324357040.USD","GLAM","LU1791710400.SGD","IE00BLSP4239.USD","KKR","LU2471134879.HKD","LU1236620834.HKD","LU0728928796.USD","REIT","ICF","LU2108987350.USD","RWR","LU0683600562.USD","LU1983260115.SGD","LU1093756325.SGD","LU2129689514.USD","LU0203201768.USD","BK4007","LU1868836914.USD","LU2361044865.SGD","LU1430594728.SGD","SG9999018865.SGD","FREL","GDOC","AAUM","SG9999013999.USD","LU1127390331.HKD","LU1979441026.SGD","LU2065171311.SGD","IE00BN29S564.USD","LU0965508806.USD","BK4585","LU2750360641.GBP","LU0170899867.USD","VFH","IYRI","LU2089984988.USD","BK4534","IE00B19Z3B42.SGD","LU2111349929.HKD","SG9999001176.USD","LU2168564495.EUR","LU2168564065.EUR","LU0094547139.USD","LU0964807845.USD","JRE","LU0052756011.USD","IE00B3QW5Z07.USD","IE00BJLML261.HKD","SG9999001176.SGD","LU2265009873.SGD","LU2361045086.USD","LU2237443549.SGD","LU0471298777.SGD","LU2552382215.SGD","KBWB","LU0545039389.USD","LU2602419157.SGD","BLCK","LU1162221912.USD","USRT","IE00BFXG1179.USD","IE000BZT7R73.USD","IE0009355771.USD","SG9999001440.SGD","HODU","LU0130102774.USD","ERET","LU2596442595.SGD","LU1934455194.USD","LU1023059063.AUD","LU2360032135.SGD","BK4528","BK4504","LU2361044949.HKD","LU0069063385.USD","LU0385154629.USD","LU1988902786.USD","LU0097036916.USD","LU2213496289.HKD","LU0122379950.USD","BK4548","LU1093756168.USD","BK4207","LU1923622614.USD","HOII","IE00BJJMRZ35.SGD","FHLC","IBBQ","LU0158827948.USD","LU2357305700.SGD","LU1883839398.USD","IYR","LU0477156797.USD","LU2750360997.AUD","MEDI","IE0002141913.USD","IYH","HEAL","LU1280957306.USD","LU1244550221.USD","IE00BLSP4452.SGD","LU2271345857.HKD","IE00B7SZLL34.SGD","BK4203","DFGR","LU0868494708.USD","LU1629891620.HKD","LU2461242641.AUD","LU2746668974.SGD","LU0321505439.SGD","LU2362541273.HKD","LU2471134523.USD","LU1917777945.USD","LU0943347566.SGD","LU0053666078.USD","LU0130517989.USD","LU0820562030.AUD","LU1084165304.USD","LU2065169927.USD","LU0306807586.USD","BK4516","LU1267930573.SGD","LU2462591350.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732665","title":"RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732665","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732665?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661000,"startTime":"0","endTime":"0","summary":"PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation Between ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350436/0/en/renovorx-highlights-peer-reviewed-publication-of-pharmacokinetic-and-pharmacodynamic-pk-pd-data-supporting-tamp-platform-s-targeted-drug-delivery-in-locally-advanced-pancreatic-can.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","LU0757428866.USD","LU0274383776.USD","MEDX","RNXT","BK4139","IE00B66KJ199.SGD","BK4017","LU1169589451.USD","BK4183","IDNA","ODD","LU1169590202.USD","LABU","NVIB","BK4218","BK4588","IAG","PK","LU2931357623.SGD","AEIS","BK4181","LU1815336091.USD","IE0009354923.USD","IE00B7SZL793.SGD","KBWY","BK4585","BK4023","BK4157","LU0345780281.USD","LU0345780521.USD","LU2089985449.USD","BK4539","PD","IE0031619046.USD","IE00B19Z4B17.USD","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662873429","title":"GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100","url":"https://stock-news.laohu8.com/highlight/detail?id=2662873429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662873429?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:15","pubTimestamp":1787660116,"startTime":"0","endTime":"0","summary":"Lokahi Therapeutics, a subsidiary of Glucotrack (GCTK), announced that it has started its initial Good Manufacturing Practice, GMP, manufacturing c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/glucotrack-subsidiary-initiates-clinical-trial-manufacturing-for-lt-100-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/glucotrack-subsidiary-initiates-clinical-trial-manufacturing-for-lt-100-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","MEDX","HYLG","EES","GDOC","IDNA","BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160672856","title":"Redefining Roles: Commercial Health Insurance Enters a New Era of Partnership in China's Next Five-Year Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1160672856","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160672856?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:10","pubTimestamp":1787659849,"startTime":"0","endTime":"0","summary":"A pivotal policy document released by the National Healthcare Security Administration in August set the stage for a fundamental shift in China's medical insurance landscape.For the first time, the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1574","MEDX","IBBQ","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171799602","title":"ETF Market Daily: Healthcare Sector Shows Solid Valuations While Innovative Drug Subsegments See Dense Catalysts, Spotlight on Hang Seng Biotech ETF and STAR Innovative Drug ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=1171799602","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171799602?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:50","pubTimestamp":1787658655,"startTime":"0","endTime":"0","summary":"Today, China's three major A-share indices delivered mixed performances, with the Shanghai Composite Index edging up 0.19%, the Shenzhen Component Index slipping 0.35%, and the ChiNext Index falling...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159316","LNGR","FDN","IBBQ","MEDX","BK4550","BK1574","159992","BK4585","BK1515","BK4588","HBImain","BK1161","09939","159892","06978","159982","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662773162","title":"Sagimet Biosciences advances AURORA clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662773162","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662773162?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:40","pubTimestamp":1787658027,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) announced that its AURORA Phase 3 clinical trial of FASN inhibitor denifanstat in moderate to severe acne is on track to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-advances-aurora-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-advances-aurora-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HYLG","NVIB","GDOC","BK4139","IDNA","MEDX","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662367737","title":"Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2662367737","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662367737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:02","pubTimestamp":1787655745,"startTime":"0","endTime":"0","summary":"Parabilis Medicines appoints former J&J oncology executive Craig Tendler to boardParabilis Medicines appointed Craig L. Tendler, M.D., to its board of directors on Aug. 25, 2026.Tendler previously led","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL3GCJSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703095.HKD","IE0002270589.USD","TRUH","NDAQ","LU1430594728.SGD","LU1894683348.USD","BCDF","LU0122379950.USD","LU0889566641.SGD","IE00BKPKM429.USD","LU1066051225.USD","LU2756315318.SGD","LU0943347566.SGD","PJP","SG9999001440.SGD","RXL","LU0234570918.USD","LU1989771016.USD","JNJ","LU0426417589.USD","SG9999001176.SGD","SG9999001176.USD","SG9999002232.USD","IE00BZ1G4Q59.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00BVYPNW00.USD","IYH","IE00B64PRP62.GBP","LU0053666078.USD","LU2112291526.USD","BMED","MEDX","VHT","LU1244550221.USD","IE00BN0W2W23.USD","BK4585","FHLC","GDOC","BK4588","FTXH","IHE","LU0210528500.USD","XLV","LU0882574055.USD","IXJ","LU1894683264.USD","BK4581","PBLS","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175741624","title":"Market Sees Gains Across More Than 4,200 Stocks as Innovative Drug Sector Surges and Gold Shares Slip | Huabao Fund 3A Daily Report (August 25, 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=1175741624","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175741624?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:40","pubTimestamp":1787654440,"startTime":"0","endTime":"0","summary":"On August 25, 2026, the broader market displayed robust momentum, with over 4,200 listed stocks advancing, reflecting a broad-based rally. The innovative drug sector emerged as a standout performer,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","06978","159562","LNGR","BK1161","MEDX","IBBQ","BK1574","GLDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125535292","title":"ETF Market Wrap (Aug 25): Interim Results Validate Innovative Drug Sector Rally While Gold's Pullback Caps Mining Stock Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1125535292","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125535292?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:40","pubTimestamp":1787647236,"startTime":"0","endTime":"0","summary":"Hong Kong's stock market experienced narrow oscillations today, with all three major indices closing slightly lower. The release of interim results has provided solid validation for the innovative...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDXD","GOLY","DBC","06978","KGLD","DGZ","IAU","RING","CMDT","DULL","02840","159562","EPU","GLDY","CERY","BK4550","BGLD","DGP","IBBQ","UGLD","AAAU","DUST","FGLD","GDX","GLDW","XLBI","GDXJ","BK4588","JNUG","UYM","SGDM","PYZ","BEGS","IGLD","OUNZ","BK4535","BK1161","SGOL","GLD","GDXW","LNGR","PALL","159992","FGDL","UGL","YGLD","GOAU","MGCmain","GDE","DZZ","VGFPF","GDXU","GBUG","FDN","PHYS","BK4207","GLDM","NANR","BTGD","IAUI","NUGT","SGDJ","GLL","IAUM","GDXY","BAR","BK4585","GLTR","USG","JDST","BK4504","MEDX","SHNY","CEF","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662813537","title":"Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662813537","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662813537?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:00","pubTimestamp":1787641221,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Eli Lilly & Co (LLY) wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LLII","LU1232071149.USD","LU0471298777.SGD","LU0823434583.USD","IE00BKDWB100.SGD","LU1145028129.USD","IE0004445239.USD","LU0345769128.USD","LU0456855351.SGD","LU0820562030.AUD","LU1629891620.HKD","LU0316494557.USD","GB00BDT5M118.USD","LU2746668974.SGD","BK4599","CANC","SGXZ81514606.USD","LU1551013342.USD","LU2750360997.AUD","LU0417517546.SGD","LU0353189680.USD","LU2362541513.USD","WDNA","LU0345770993.USD","LU2089283258.USD","LU0266013472.USD","LU0466842654.USD","LU0882574139.USD","SG9999014880.SGD","IYH","LU0786609619.USD","LU1551013425.SGD","LU2237438978.USD","LU2602419157.SGD","LU0320765059.SGD","LU2506952097.USD","SG9999013999.USD","ELIL","LU2462157665.USD","LU2756315664.SGD","LU1989772840.SGD","OZEM","LU0251132253.USD","LU1804176565.USD","LU1868836757.USD","LU0820561818.USD","IE00BN29S564.USD","LU1061106388.HKD","LU2361044949.HKD","LU1127390331.HKD","LU1712237335.SGD","LU0320765992.SGD","LU1974910355.USD","IE00BJJMRX11.SGD","LU1267930730.SGD","LU2236285917.USD","RXL","LLYX","LU0106261372.USD","ELIS","FTXH","LU2746668461.USD","SG9999015978.USD","LU0823417737.USD","LU1814569148.SGD","IE00B2B36J28.USD","SG9999017495.SGD","IE0009355771.USD","LU1280957306.USD","LU2552382215.SGD","IE00BFSS8Q28.SGD","LU0174119429.USD","LU2461242641.AUD","LU2471134796.USD","SGXZ57979304.SGD","TRUH","LU2168563687.JPY","LU0823417653.USD","LU1023059063.AUD","LU1718418525.SGD","LU0354030511.USD","LU1720051108.HKD","LU2211815571.USD","LU1153585028.USD","LU0943347566.SGD","LU0133085943.USD","LU2360106947.USD","LU2242649171.HKD","LU2361044865.SGD","LU1093756168.USD","LU0061475181.USD","LU2471134523.USD","BK4504","LU2456880835.USD","LU0672654240.SGD","LU0354030438.USD","LU1989764748.USD","LU2491050071.SGD","LU0097036916.USD","IHE","LLYZ","LU0109391861.USD","BK4585","IE00BK4W5L77.USD","LU0048584097.USD","LU0109394709.USD","IE00BKPKM429.USD","LU2087625088.SGD","LU2417539215.USD","LU0267386448.USD","LU0820561909.HKD","LU2362540622.SGD","MEDI","BK4534","LU2324357040.USD","FHLC","LU2506951875.HKD","LU0964807845.USD","LLY","SGXZ31699556.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4007","LU0158827948.USD","LU0432979614.USD","LU2506951958.HKD","SG9999001176.USD","LU2362541273.HKD","LU2237443622.USD","LU0058720904.USD","MEDX","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0203202063.USD","LU2089284900.SGD","LU2264538146.SGD","SG9999018857.SGD","LU2462591350.SGD","LU2028103732.USD","LU0689472784.USD","LU0138981039.USD","AGNG","LU0225283273.USD","PPH","LU1548497426.USD","IE00BK4W5M84.HKD","SG9999015986.USD","LU0323591593.USD","LU1064131342.USD","IE00B1XK9C88.USD","LU1983299246.USD","LU1989771016.USD","SG9999014898.SGD","LU2271345857.HKD","LU0683600562.USD","LU0353189763.USD","IE00BFSS7M15.SGD","LU1988902786.USD","LU1791710582.SGD","IE0005OL40V9.USD","LU0882574055.USD","LU2108987350.USD","LU2750360641.GBP","LU0187121727.USD","LU1069344957.HKD","BK4533","SG9999014914.USD","LU0011850046.USD","LU0345770308.USD","LU0889565916.HKD","LU1366192091.USD","LU2552382132.HKD","LU1791710400.SGD","LU2265009873.SGD","LU0256863811.USD","IE00BJT1NW94.SGD","GDOC","LU2023251221.USD","LU2023250330.USD","LU2237443978.SGD","LU1868836591.USD","LU2237443895.HKD","SG9999018865.SGD","LU1057294990.SGD","LU2491050154.USD","LU0203201768.USD","LU0096364046.USD","LU2468319806.SGD","BK4082","SG9999015952.SGD","LU1323610961.USD","SG9999014906.USD","LU0114720955.EUR","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0708995401.HKD","LU2237443549.SGD","LU2896262040.SGD","LU1989772923.USD","LU0234572021.USD","VHT","LU0158827781.USD","LU0006306889.USD","TMED","JDOC","LU2168564222.USD","LU0640476718.USD","LU1868837300.USD","LU0345769631.USD","PJP","LU0471298694.HKD","LU2168564495.EUR","LU2237443382.USD","LU2168564065.EUR","HRTS","LU0950375773.USD","LU2244417387.USD","LU1691799644.USD","SGXZ99366536.SGD","LU2357305700.SGD","LU2506952170.USD","LU0077335932.USD","IE00BWXC8680.SGD","LU2552382058.USD","IXJ","SGXZ51526630.SGD","LU1093756325.SGD","LU2168564149.EUR","LU2237443465.HKD","IE00B4JS1V06.HKD","IE00BJLML261.HKD","LU1720051017.SGD","THNR","LU0079474960.USD","SG9999015945.SGD","LU2491049909.HKD","LU0823416689.USD","SG9999001176.SGD","LU0094547139.USD","LU0198837287.USD","LU2063271972.USD","IE00B4R5TH58.HKD","LU2471134952.CNY","LU2213496289.HKD","LU2089984988.USD","IE0002141913.USD","LU0385154629.USD","LU2023250504.SGD","IE00BJJMRY28.SGD","IE00BFTCPJ56.SGD","LU2756315318.SGD","LU1868836914.USD","BSX","IE00B775H168.HKD","LU0256863902.USD","BK4588","LU2106854487.HKD","IE0004445015.USD","LU2112291526.USD","LU1623119135.USD","LU2111349929.HKD","LU0289739699.SGD","BK4581","LU1917777945.USD","BK4516","LU1989764664.SGD","LU0528227936.USD","CURE","LU0787776722.HKD","LU1035775433.USD","LU2471134879.HKD","LU1868837136.USD","LU2361045086.USD","ILDR","LU0210536198.USD","LU0238689110.USD","LU0823434740.USD","LU1979441026.SGD","MHIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662978521","title":"Molecular Partners H1 Net Loss Narrows on Lower R&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2662978521","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662978521?lang=en_us&edition=fundamental","pubTime":"2026-08-25 13:14","pubTimestamp":1787634840,"startTime":"0","endTime":"0","summary":"Molecular Partners H1 net loss narrows on lower R&D expensesOverviewSwitzerland biotech reported no H1 revenue and a reduced net loss as R&D expenses declinedCompany advanced lead Radio-DARP in candid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M03N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089283258.USD","LU0795875086.SGD","01167","IE00BSNM7G36.USD","LU0661504455.SGD","AGNG","LU0058720904.USD","LU2023251221.USD","PJP","IE00BN8TJ469.HKD","FHLC","LU0158827948.USD","IXJ","LU1244550494.USD","LU1934455277.USD","LU1732799900.SGD","FTXH","LU1244550577.SGD","GLAM","LU0795875169.SGD","LU2112291526.USD","MEDX","VHT","LU0203345920.USD","LU1023059063.AUD","RXL","IE00B19Z3B42.SGD","SG9999011175.SGD","LU0456855351.SGD","LU0823416689.USD","BK0239","XLV","IYH","TRUH","LU0310800379.SGD","LU1064130708.USD","688428","LU1551013342.USD","LU0689472784.USD","BK4581","ABBV","LU0234570918.USD","LU2237443382.USD","LU0868494708.USD","LU1244550221.USD","JDOC","688331","PPH","LU0553294199.USD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180698153","title":"Coordinated Growth Fuels Regional Industrial Advancement","url":"https://stock-news.laohu8.com/highlight/detail?id=1180698153","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180698153?lang=en_us&edition=fundamental","pubTime":"2026-08-25 08:31","pubTimestamp":1787617905,"startTime":"0","endTime":"0","summary":"On August 19, technical staff at Guoke Saifu Hebei Pharmaceutical Technology Co., Ltd. were conducting innovative drug trials. In recent years, Gu'an County has seized the opportunity presented by...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662320194","title":"US FDA Expands Approval for J&J's Drug for Rare Blood Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2662320194","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662320194?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:32","pubTimestamp":1787610721,"startTime":"0","endTime":"0","summary":"US FDA expands approval for J&J's drug for rare blood disorderAug 24 (Reuters)-The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson'sJNJ.Ndrug to treat a rare blood disorder, the company said on Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L1IK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU1145028129.USD","LU2456880835.USD","JDOC","IE0002270589.USD","LU0124676726.USD","LU1935042991.SGD","IE00B7SZLL34.SGD","LU1894683264.USD","IE00BJT1NW94.SGD","IYH","PJP","SGXZ80539844.SGD","RXL","IXJ","VHT","BK4504","LU1196500208.SGD","LU2236285917.USD","IE00BN8TJ469.HKD","LU1989771016.USD","LU2430703095.HKD","LU0787776722.HKD","LU2129689514.USD","BMED","IE00BLSP4239.USD","FHLC","GDOC","LU1551013342.USD","LU1732799900.SGD","LU2089984988.USD","BK4550","LU1244550577.SGD","LU2756315664.SGD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU0098860793.USD","IHE","IE00BKVL7J92.USD","TRUH","SG9999001176.SGD","XLV","JNJ","LU0985320562.USD","LU1585245621.USD","IE00BSNM7G36.USD","IE00BDGV0183.EUR","LU2468319806.SGD","FTXH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662913201","title":"FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662913201","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662913201?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:31","pubTimestamp":1787610683,"startTime":"0","endTime":"0","summary":"FDA approves J&J IMAAVY for warm autoimmune hemolytic anemia treatmentFDA cleared IMAAVY  for warm autoimmune hemolytic anemia in patients aged 12+ who are current or prior corticosteroid users.Decision makes IMAAVY the first treatment specifically proven safe and effective for wAIHA, based on the Phase 2/3 ENERGY trial.Trial data showed a mean hemoglobin increase of 1 g/dL at Week 1, with improved FACIT-Fatigue scores at Week 24.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL9KyWks:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","LU1032466523.USD","FTXH","LU0234572021.USD","LU1585245621.USD","LU1059921491.USD","BMED","LU2505996509.AUD","IE00BFXG1179.USD","LU1674673428.USD","LU0689626769.HKD","IE0002270589.USD","JDOC","SG9999001440.SGD","LU0820561909.HKD","LU2471134796.USD","LU0124676726.USD","IE0034235303.USD","TRUH","LU2133065610.SGD","LU2129689514.USD","LU1732799900.SGD","SGXZ57979304.SGD","IXJ","LU0795875086.SGD","IE00B3PB1722.GBP","LU0640476718.USD","JNJ","LU2347655156.SGD","IHE","RXL","LU2129689605.HKD","XLV","IE000SO60NU8.SGD","FHLC","LU0545562505.USD","VHT","LU1221951129.SGD","LU2430703251.USD","MEDX","IE00BVYPNW00.USD","LU1066051225.USD","LU1244550494.USD","LU0683600562.USD","LU0792757196.USD","PJP","SGXZ80539844.SGD","GDOC","BK4504","LU2602419157.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662620199","title":"Alkermes’ Alixorexton Posts Positive Phase 2 Vibrance-1 Results in Narcolepsy Type 1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2662620199","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662620199?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:30","pubTimestamp":1787610625,"startTime":"0","endTime":"0","summary":"Alkermes’ alixorexton posts positive Phase 2 Vibrance-1 results in narcolepsy type 1 studyAlkermes reported publication of positive Phase 2 Vibrance-1 results for alixorexton in adults with narcolepsy type 1 in The Lancet Neurology.Results were previously announced, not newly presented, showing improved daytime wakefulness and sleepiness measures versus placebo.Study also indicated reduced cataplexy at one dose, with broader patient-reported benefits in daily functioning.Safety profile appeared generally well tolerated, with mostly mild-to-moderate adverse events and no serious treatment-emergent events reported.Positive Phase 2 readouts supported the launch of the global Phase 3 Brilliance program testing once-daily and split-dose regimens in narcolepsy types 1 and 2.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpos","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL56tjq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","PSCH","PSIL","MEDX","ALKS","BK4139","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662201993","title":"The Lancet Neurology Publishes Data from Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults with Narcolepsy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2662201993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662201993?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:30","pubTimestamp":1787610600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA7VQ936:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","PSIL","PSCH","IBRN","FBT","ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662016052","title":"FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662016052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662016052?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:29","pubTimestamp":1787610556,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1061106388.HKD","FTXH","VHT","IE00BDGV0183.EUR","IE000BZT7R73.USD","LU1244550221.USD","LU1506573853.SGD","JDOC","LU0114720955.EUR","LU0345769128.USD","LU0345769631.USD","IYH","IE0034235303.USD","LU1228905540.USD","LU2430703178.SGD","SG9999002232.USD","XLV","LU1043141396.HKD","LU0889566641.SGD","LU0426417589.USD","PJP","LU0466842654.USD","JNJ","IXJ","RXL","LU0122379950.USD","GDOC","IE00B19Z3B42.SGD","BK4532","SGXZ57979304.SGD","LU2129689514.USD","LU0640476718.USD","LU0124676726.USD","LU0070217475.USD","FHLC","IE00B42XCP33.USD","MEDX","TRUH","LU1261432733.SGD","LU2487616109.SGD","SG9999002224.SGD","BMED","LU1162221912.USD","IE0002270589.USD","LU1221951046.USD","LU2347655156.SGD","LU2756315664.SGD","LU0964807845.USD","LU1280957306.USD","IHE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":9,"totalSize":230,"code":"91000000","status":"200"}]}}